From: Alleviating effects of morin against experimentally-induced diabetic osteopenia
 | Control | STZ | STZ+M15 | STZ+M30 |
---|---|---|---|---|
BMD (g/cm3) | 0.772±0.022 | 0.627±0.011**a | 0.653±0.034 | 0.732±0.025*b |
BV/TV (%) | 0.444±0.021 | 0.277±0.021**a | 0.341±0.018 | 0.369±0.028*b |
SMI | 0.874±0.101 | 1.655±0.101**a | 1.381±0.131 | 1.298±0.137 |
Tb.N (mm-1) | 3.534±0.143 | 2.515±0.197*a | 2.914±0.165 | 3.339±0.202*b |
Tb.Sp (mm) | 0.173±0.011 | 0.224±0.009*a | 0.197±0.002 | 0.176±0.009*b |
Tb.Th (mm) | 0.123±0.002 | 0.107±0.002**a | 0.115±0.001 | 0.118±0.002*b |
Tb.Po (%) | 58.614±1.382 | 66.537±0.611*a | 61.038±1.643 | 58.285±2.532*b |